Brief: Biosynex Acquires A 23.31% Stake In PRIMADIAG

Biosynex SA

20/04/2022 17:22

April 20 (Reuters) - Biosynex SA  ALBIO.PA :
    * BIOSYNEX ANNOUNCES IT HAS ACQUIRED A 23.31% STAKE IN
PRIMADIAG
    * BIOSYNEX DOES NOT EXCLUDE POSSIBILITY OF INCREASING ITS
STAKE AT
LATER STAGE OR PROVIDE FINANCING TO PRIMADIAG IN ORDER TO
SUPPORT ITS  DEVELOPMENT
    * THIS COMBINED OFFER SHOULD ENABLE BIOSYNEX TO ACCELERATE
ITS
DEPLOYMENT IN THE FAST GROWING MOLECULAR BIOLOGY MARKET
    * BIOSYNEX HOPES THAT THIS MERGER WILL LEAD TO AN INDUSTRIAL
PARTNERSHIP BETWEEN THE TWO COMPANIES
    * BIOSYNEX PLANS TO ACCOMPANY THIS OPERATION WITH FUTURE
INDUSTRIAL PARTNERSHIP THAT WOULD ENABLE GROUP TO OFFER COMPLETE
SOLUTION TO PRIVATE MEDICAL LABORATORIES, HOSPITAL

Source text for Eikon:  ID:nEQbynsbFa 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))